Estocang Biopharmaceutical (Tianjin) Co., Ltd. was established in August 2020. It is a new drug research and development enterprise based in China and facing the world. It is committed to the development of innovative drugs in the fields of oncology, metabolism, and other life-threatening diseases.

Disease Domain	Count

Neoplasms	4
Hemic and Lymphatic Diseases	3
Immune System Diseases	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Small molecule drug	2
Therapeutic vaccine	1
Proteolysis-targeting chimeras (PROTAC)	1
mRNA vaccine	1

Top 5 Target	Count

EZH2(Histone-lysine N-methyltransferase EZH2)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 19 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

AXT1003 ( EZH2 )	Sarcoma More	Preclinical
AXT1005	Adult Acute Myeloblastic Leukemia More	Preclinical
AXT-3001	Leukemia More	Preclinical
AXT-2001	Sarcoma More	Discovery
AXT-2002	Liver Cancer More	Discontinued

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis